Literature DB >> 10030688

Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells.

T C Skaar1, S C Prasad, S Sharareh, M E Lippman, N Brünner, R Clarke.   

Abstract

We have used two-dimensional gel electrophoresis to identify proteins associated with estrogen-induced proliferation in MCF-7 breast cancer cells and their progression to estrogen-independent proliferation. We compared the total cellular proteins from MCF-7 cells and an estrogen independent derivative of the MCF-7 cells MCF-7/LCC1 (Brünner et al. Cancer Research 1993, 53, 283-290), each grown with and without estradiol. These comparisons reveal seven estrogen-regulated proteins. Three of these proteins (HI-1: 36 kDa/pI 4.5, HI-10: 40 kDa/pI 5.5 and HI-19: 62 kDa/pI 5.0) exhibit a 'progression-like' pattern, being induced by estradiol in MCF-7 cells and constitutively present/upregulated in the MCF-7/LCC1 growing without estradiol. HI-11 (65 kDa/pI 5.5) is strongly induced by estradiol in MCF-7 cells but constitutively downregulated and unresponsive to estradiol in the MCF-7/LCC1 cells. Two proteins exhibit a suppressor pattern and are downregulated by estradiol in the estrogen-dependent MCF-7 cells (HI-3: 44 kDa/pI 4.4 and HI-4: 56 kDa/ pI 5.2) and present in MCF-7/LCC1 cells growing without estradiol at levels comparable to that seen in estrogen-treated MCF-7 cells. One protein (HI-9: 68 kDa/pI 5.5) exhibits a marked estrogen regulated pI shift, rather than changes in abundance. We purified and sequenced the HI-10 protein, which we identified as the nucleolar protein, nucleophosmin (NPM). One- and two-dimensional Western blot analyses of MCF-7/LCC1 cell lysates confirmed that HI-10 is immunoreactive with an antinucleophosmin antibody. Western blotting also confirmed the estrogenic regulation of NPM seen in the initial two-dimensional gel electrophoresis studies. Thus, NPM is induced by estradiol in the MCF-7 cells and upregulated in the MCF-7/LCC1 cells growing without estrogen, clearly associating its expression with an acquired estrogen-independent phenotype. NPM has several potentially important roles in regulating cell function and signaling. It is a substrate for phosphorylation by p34cdc2 kinase, protein kinase C and nuclear kinase II, and a repressor of the transcriptional regulating activities of both the IRF-1 tumor suppressor protein and the YY1 transcription factor. Studies are currently underway to determine which of these NPM functions may be involved in the hormonal progression of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10030688     DOI: 10.1016/s0960-0760(98)00142-3

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  22 in total

Review 1.  The properties of high-dimensional data spaces: implications for exploring gene and protein expression data.

Authors:  Robert Clarke; Habtom W Ressom; Antai Wang; Jianhua Xuan; Minetta C Liu; Edmund A Gehan; Yue Wang
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

2.  Genome-wide analysis of interferon regulatory factor I binding in primary human monocytes.

Authors:  Lihua Shi; Juan C Perin; Jeremy Leipzig; Zhe Zhang; Kathleen E Sullivan
Journal:  Gene       Date:  2011-07-19       Impact factor: 3.688

3.  An extensive tumor array analysis supports tumor suppressive role for nucleophosmin in breast cancer.

Authors:  Piia-Riitta Karhemo; Antti Rivinoja; Johan Lundin; Maija Hyvönen; Anastasiya Chernenko; Johanna Lammi; Harri Sihto; Mikael Lundin; Päivi Heikkilä; Heikki Joensuu; Petri Bono; Pirjo Laakkonen
Journal:  Am J Pathol       Date:  2011-06-02       Impact factor: 4.307

4.  Nucleophosmin delocalization in thyroid tumour cells.

Authors:  Annalisa Pianta; Cinzia Puppin; Nadia Passon; Alessandra Franzoni; Milena Romanello; Gianluca Tell; Carla Di Loreto; Stefania Bulotta; Diego Russo; Giuseppe Damante
Journal:  Endocr Pathol       Date:  2011-03       Impact factor: 3.943

5.  Mass spectrometric characterization of protein structure details refines the proteome signature for invasive ductal breast carcinoma.

Authors:  Claudia Röwer; Cornelia Koy; Michael Hecker; Toralf Reimer; Bernd Gerber; Hans-Jürgen Thiesen; Michael O Glocker
Journal:  J Am Soc Mass Spectrom       Date:  2011-02-08       Impact factor: 3.109

6.  Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

Authors:  Robert Clarke; Ayesha N Shajahan; Rebecca B Riggins; Younsook Cho; Anatasha Crawford; Jianhua Xuan; Yue Wang; Alan Zwart; Ruchi Nehra; Minetta C Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03       Impact factor: 4.292

7.  Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter.

Authors:  Luigi Cicatiello; Raffaele Addeo; Annarita Sasso; Lucia Altucci; Valeria Belsito Petrizzi; Raphaelle Borgo; Massimo Cancemi; Simona Caporali; Silvana Caristi; Claudio Scafoglio; Diana Teti; Francesco Bresciani; Bruno Perillo; Alessandro Weisz
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

8.  Estrogen stimulates the proliferation of human endometrial cancer cells by stabilizing nucleophosmin/B23 (NPM/B23).

Authors:  Angel Chao; Chiao-Yun Lin; Chia-Lung Tsai; Swei Hsueh; Ying-Yu Lin; Cheng-Tao Lin; Hung-Hsueh Chou; Tzu-Hao Wang; Chyong-Huey Lai; Hsin-Shih Wang
Journal:  J Mol Med (Berl)       Date:  2012-08-29       Impact factor: 4.599

9.  Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions.

Authors:  Isabelle Mercier; Mathew C Casimiro; Jie Zhou; Chenguang Wang; Christopher Plymire; Kelly G Bryant; Kristin M Daumer; Federica Sotgia; Gloria Bonuccelli; Agnieszka K Witkiewicz; Justin Lin; Thai Hong Tran; Janet Milliman; Philippe G Frank; Jean-François Jasmin; Hallgeir Rui; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2009-04       Impact factor: 4.307

10.  Regulation of subcellular distribution and oncogenic potential of nucleophosmin by plakoglobin.

Authors:  L Lam; Z Aktary; M Bishay; C Werkman; C-Y Kuo; M Heacock; N Srivastava; J R Mackey; M Pasdar
Journal:  Oncogenesis       Date:  2012-03-19       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.